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Enterotoxigenic Escherichia coli (ETEC), a major global cause of diarrhea,
initiates the pathogenic process via ﬁmbriae-mediated attachment to the small
intestinal epithelium. A common prototypic ETEC ﬁmbria, colonization factor
antigen I (CFA/I), consists of a tip-localized minor adhesive subunit CfaE and
the stalk-forming major subunit CfaB, both of which are necessary for ﬁmbrial
assembly. To elucidate the structure of CFA/I at atomic resolution, three recom-
binant proteins were generated consisting of fusions of the minor and major
subunits (CfaEB) and of two (CfaBB) and three (CfaBBB) repeats of the major
subunit. Crystals of CfaEB diffracted X-rays to 2.1 A ˚ resolution and displayed
the symmetry of space group P21. CfaBB exhibited a crystal diffraction limit of
2.3 A ˚ resolution and had the symmetry of space group P21212. CfaBBB
crystallized in the monoclinic space group C2 and diffracted X-rays to 2.3 A ˚
resolution. These structures were determined using the molecular-replacement
method.
1. Introduction
Although it has been almost 40 years since it was ﬁrst implicated as a
prevalent cause of travelers’diarrhea and as a leading bacterial cause
of diarrhea morbidity and mortality in young children in developing
countries (Rowe et al., 1970; Black et al., 1981), human-speciﬁc
enterotoxigenic Escherichia coli (ETEC) has until recently largely
escaped structural examination of its adhesive machinery. Central to
the pathogenesis of ETEC-induced secretory diarrhea is the ability of
the organism to adhere to the small intestinal mucosa via adhesive
ﬁmbriae or colonization factors (Turner et al., 2006). Although nearly
two dozen such colonization factors have been described, little is
known about the molecular details of their structure and function
(Gaastra & Svennerholm, 1996; Steinsland et al., 2003).
Colonization factor antigen I (CFA/I) was the ﬁrst such adhesive
ﬁmbria to be discovered and is the archetype of eight class 5 ETEC
ﬁmbriae (Evans et al., 1978; Anantha et al., 2004). Of the other seven
class 5 ﬁmbriae, CS1 ﬁmbriae have been extensively studied, parti-
cularly their biogenesis and regulation (Sakellaris et al., 1996, 1999;
Munson et al., 2002). Like CS1, CFA/I is encoded by a four-gene
operon and is assembled by the alternate chaperone pathway, which
has been distinguished from the classic chaperone–usher pathway
that guides the assembly of class I pili such as type 1 and P pili (Soto
& Hultgren, 1999; Anantha et al., 2004). CFA/I ﬁmbriae are hetero-
polymeric structures that are composed of a tip-localized minor
adhesive subunit (CfaE) subjoined toa homopolymeric tract of >1000
CfaB major subunits (Sakellaris & Scott, 1998; Poole et al., 2007; Li
et al., 2007; Mu et al., 2008). Bioassembly is orchestrated by a peri-
plasmic chaperone (CfaA), which promotes proper subunit folding
and delivery to an outer membrane usher protein (CfaC), which
extrudes the subunits in an ordered fashion to form a regular helical
superstructure (Sakellaris & Scott, 1998; Anantha et al., 2004; Mu
et al., 2008). The donor-strand complementation and exchange
mechanism, ﬁrst discovered in structural investigations of type 1 and
P pili (Sauer et al., 1999; Choudhury et al., 1999), also appears to be a
hallmark of class 5 ﬁmbrial biogenesis (Poole et al., 2007; Li et al.,
2007).Recent structural studies have begun to elucidate the molecular
details of CFA/I ﬁmbriae. We have reported the crystal structure of
the CfaE tip adhesin, which shows similarities to the two-domain
structures of certain other Gram-negative adhesins, including FimH
from type 1 ﬁmbriae and PapG from P pili (Li et al., 2007). A three-
dimensional helical reconstruction of CFA/I ﬁmbriae has also been
reported based on transmission electron microscopy of a negatively
stained CFA/I specimen, revealing a right-handed helix for the CfaB
ﬁlament with weak inter-coil interactions (Mu et al., 2008).
Building upon this structural framework will require atomic level
details of the structure of the major subunit CfaB. In approaching this
aim, we have drawn upon the difﬁculties and successes encountered
in atomic structure determination of major subunits of class I pili as
well as nonclassical ﬁlamentous structures of the chaperone–usher
pathway. Only recently has the ﬁrst major subunit of a classical
helically coiled pilus structure been determined: that of PapA, which
required the introduction of several mutations and cocrystallization
with its chaperone (Verger et al., 2007). In contrast, the structures of a
number of major subunits of nonclassical ﬁbrillar or aﬁmbrial sheath
structures have been solved using various approaches (Zavialov et al.,
2003; Pettigrew et al., 2004; Anderson et al., 2004; Van Molle et al.,
2007). After unsuccessful attempts to crystallize a unitary in cis
donor-strand complemented form of CfaB, we adopted a novel
strategy to tandemly fuse two or more CFA/I subunits in order to
emulate the native noncovalent linkages formed by donor-strand
exchange. Here, we report the engineering of three different recom-
binant fusion proteins each containing one or more CfaB units with a
C-terminal extension comprising the donor  -strand of CfaB to
achieve protein stability. Each of these proteins, consisting of in-
tandem arrangements of minor–major, major–major and major–
major–major subunits, were puriﬁed in soluble form and crystallized.
The structure solutions of these three fusions are expected to provide
the structural basis for dissecting the function of CFA/I ﬁmbriae at
the submolecular level.
2. Materials and methods
2.1. Construction of expression vectors for recombinant CfaEB,
CfaBB and CfaBBB fusion proteins
2.1.1. Construction of pET24-2lnkdsc19cfaEB(his)6.T h ecfaB gene
was ampliﬁed by PCR using the primers cfaB (reverse), 50-GTG-
GTGGTGGTGGTGCTCGAGGGATCCCAAAGTCATTACAAG-
AGA-30, and cfaB (forward), 50-GTAGAGAAAAATATTACTGTA-
ACAGC-30, using pNTP513 as template (Hibberd et al., 1991). The
resulting product was inserted at the 50-end of cfaE in pET24-
dsc19cfaE(his)6 (Poole etal., 2007;Lietal., 2006)bysite-directedmuta-
genesis (QuikChange Kit, Stratagene, La Jolla, California, USA) to
form the intermediate construct pET24-lnkcfaEB(his)6. The coding
sequence for a short linker (DNKQ) followed by the N-terminal
donor  -strand (19 residues) of CfaB (‘DNKQ-dsc19’) was ampliﬁed
by PCR from pET24-dsc19cfaE(his)6 using primers containing
BamHI and XhoI sites (forward, 50-CGCCGCGGATCCGACAA-
GACAATAAACAAGTAGAGAAAAATATT-30; reverse, 50-CCG-
CCGCTCGAGTTGCAAAAGATCAATCACAGGATC-30). Diges-
tion of pET24-lnkcfaEB(his)6 and the ‘DNKQ-dsc19’ PCR product
with BamHI and XhoI and subsequent ligation yielded the ﬁnal
plasmid construct pET24-2lnkdsc19cfaEB(his)6. This plasmid, which
contains an LEHHHHHH tag at the C-terminus for ease of puriﬁ-
cation, was transformed into E. coli BL21(DE3) for expression.
2.1.2. Construction of pET24-2lnkdsc15cfaBB(his)6.T h ecfaB gene
was ampliﬁed by PCR from the wild-type ETEC strain H10407
(ATCC) with the primers 50-ACATATGATTGATCTTTTGCAAG-
CTGATGGC-30 (forward) and 50-CTCGAGAATTGCAGGATCA-
ACACTAGCTGTTACAGTAATATTTTTCTCTACCTGTTTGTT-
ATCGGATCCCAAAGTCATTACAAGAGATACTAC-30 (reverse);
the latter contains the coding sequence for ‘DNKQ-dsc15’. The cfaB
fragment was then cloned into pET24a(+) pre-digested with NdeIand
XhoI. Subsequently, the cfaB gene was PCR-ampliﬁed again with two
pairs of primers [the NdeI and SacI pair, 50-ACATATGATTGATCT-
TTTGCAAGCTGATGGC-30 (forward) and 50-AGAGCTCAATT-
GCAGGATCAACACTAGCTGTTA-30 (reverse), and the SacI and
XhoI pair 50-AGAGCTCTTGCAAGCTGATGGCAATGCTCTG-
CCA-30 (forward) and 50-AAGCTTAATTGCAGGATCAACACTA-
GCTGTTA-30 (reverse)], which were cloned into the TOPO cloning
vector pCRXL-TOPO separately and transformed into OneShot
Top10F competent cells. Each cfaB gene was conﬁrmed by DNA
sequencing and the respective plasmids were digested with either
NdeI and SacIo rSacI and XhoI. DNA fragments were recovered
after separation by agarose-gel electrophoresis and ligated into
similarly digested vector pET24a(+). The desired plasmids with two
tandem cfaB gene segments were identiﬁed by restriction analysis
and conﬁrmed by DNA sequencing. The pET24-2lnkdsc15cfaBB(his)6
plasmid, which contains an LEHHHHHH tag at the C-terminus for
ease of puriﬁcation, was transformed into E. coli BL21(DE3) for
expression.
2.1.3. Construction of pET24-3lnkdsc15cfaBBB(his)6. Similarly,
pET24-3lnkdsc15cfaBBB(His)6 was constructed with three copies of
cfaB ampliﬁed using three sets of primers [the NdeI and SacI pair,
50-TAACAGCTAGTGTTGATCCTGCAATTTGAAAGCTT-30 (for-
ward) and 50-AGAGCTCAATTGCAGGATCAACACTAGCTGTT-
A-30 (reverse), the SacI and HindIII pair, 50-AGAGCTCTTGCAA-
GCTGATGGCAATGCTCTGCCA-30 (forward) and 50-AAGCT-
TAATTGCAGGATCAACACTAGCTGTTA-30 (reverse), and the
HindIII and XhoI pair, 50-AAGCTTTTGCAAGCTGATGGCAAT-
GCTCTGCCA-30 (forward) and 50-CTCGAGAATTGCAGGATCA-
ACACTAGCTGTTACAGTAATATTTTTCTCTACCTGTTTGTTA-
TCGGATCCCAAAGTCATTACAAGAGATACTAC-30 (reverse)],
which were subsequently cloned into the pCRXL-TOPO plasmid and
conﬁrmed by DNA sequencing. The three cfaB genes were released
with respective restriction enzymes and ligated to pET24a(+) pre-
digested by NdeI and XhoI to yield pET24-3lnkdsc15CfaBBB(His)6.
This plasmid also contains an LEHHHHHH tag at the C-terminus for
ease of puriﬁcation.
2.2. Expression and purification of CfaEB, CfaBB and CfaBBB
2.2.1. Purification of dscCfaEB(His)6. Cultures of BL21(DE3)/
pET24-2lnkdsc19dsc19cfaEB(his)6 were grown at 305 K in the alter-
native protein source Super Broth (Difco, Detroit, Michigan, USA)
with 50 mgm l
 1 kanamycin to late logarithmic phase and induced
with 1 mM IPTG for 3 h. Harvested cell pellets were resuspended in
1:4(w:v) buffer A (20 mM phosphate, 500 mM NaCl, 50 mM imida-
zole pH 7.4) and subjected to disruption by microﬂuidization (Model
M110-Y Apparatus, Microﬂuidic Corp., Newton, Massachusetts,
USA). The lysate was centrifuged at 17 000g for 45 min at 277 K. The
supernatant was loaded onto a HisTrap FF column (GE Healthcare,
Piscataway, New Jersey, USA) equilibrated with buffer A. Protein
was eluted with a gradient to 300 mM imidazole over 20 column
volumes (CVs). Fractions containing the protein of interest were
resolved by SDS–PAGE and detected by Western blotting using anti-
dscCfaE antibodies (Poole et al., 2007). These fractions were pooled
and diluted tenfold with buffer B (25 mM MES pH 6.0) before
loading onto a HiTrap SP column (GE Healthcare, Piscataway, New
crystallization communications
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gradient to 500 mM NaCl over 20 CVs. Fractions containing
dsc19CfaEB(His)6 (hereafter called CfaEB) were pooled, concen-
trated with an Amicon Ultra-15 centrifugal ﬁlter (Millipore, Billerica,
Massachusetts, USA) and applied onto a Superdex 75 10/300 GL
column equilibrated with phosphate-buffered saline pH 6.7. Fractions
containing CfaEB were pooled and concentrated to  10 mg ml
 1.
The purity of the ﬁnal pooled sample was determined by densito-
metric analysis of an SDS–PAGE gel. The protein concentration was
determined using the BCA assay (Pierce, Rockford, Illinois, USA)
and its identity was conﬁrmed by N-terminal sequence analysis and
Western blotting using anti-dscCfaE and anti-dscCfaB antibodies
(Poole et al., 2007).
2.2.2. Purification of dscCfaBB(His)6 and dscCfaBBB(His)6.T h e
procedures used for the puriﬁcation of dscCfaBB and dscCfaBBB
wereidentical.Speciﬁcally,BL21(DE3)strainharboringeitherpET24-
2lnkdsc15cfaBB(his)6 or pET24-3lnkdsc15cfaBBB(his)6 was grown at
310 K in Super Broth supplemented with 50 mgl
 1 kanamycin and
induced with 1 mM IPTG. Cells were washed, suspended in phos-
phate-buffered saline (PBS) containing a protease-inhibitor cocktail
(Sigma, St Louis, Missouri, USA), and disrupted by two passes
through a French Press operated at 10.3 MPa. After centrifugation,
the supernatant was applied onto Ni–NTA resin and eluted with an
automated program controlled by the A ¨ KTA FPLC system (GE
Healthcare) in a buffer containing 20 mM Tris–HCl pH 8.0, 0.5 M
NaCl and a varying imidazole concentration from 10 to 500 mM.T h e
dsc15CfaBB(His)6 or dsc15CfaBBB(His)6 (hereafter called CfaBB or
CfaBBB, respectively) fractions were pooled and ammonium sulfate
(AS) was added to achieve 40% saturation before application onto a
Phenyl-Sepharose column pre-equilibrated with 40% saturated AS in
20 mM Tris–HCl pH 7.5. The elution gradient was 40–0% AS in the
same buffer. Puriﬁed CfaBB or CfaBBB fractions were pooled and
dialyzed against a buffer containing 20 mM Tris–HCl pH 7.5 with
100 mM NaCl. To determine the apparent molecular weight, puriﬁed
CfaBB/CfaBBB was analyzed on a Superdex 200 size-exclusion
column operated in a buffer consisting of 20 mM Tris–HCl pH 7.5,
200 mM NaCl.
2.3. Crystallization, diffraction data collection and reduction
CfaEB, CfaBB and CfaBBB were crystallized using the vapor-
diffusion method at 288 K. Typically, initial crystallization screening
was performed robotically with a Mosquito automated solution
dispenser (TTP LabTech) coupled with commercially available high-
throughput screening kits (Hampton Research and Molecular
Dimensions) in a hanging-drop format. Each droplet was a mixture of
300 nl protein and 300 nl reservoir solution and a volume of 50 ml
reservoir solution was employed. Conditions for initial hits were
repeated and conﬁrmed with solutions prepared in-house. The initial
conditions were identiﬁed as D1, D6 and D11 of MemStart MemSys
HT96 from Molecular Dimensions for CfaEB, while that for CfaBB
was found to be G12 of IndexHT from Hampton Research and those
for CfaBBB were A10, B8, D6 and F1 of Crystal Screen HT from
Hampton Research. For optimization, additive screening kits from
commercial screens (Hampton Research) were used in a high-
throughput setting. Productive crystallization followed optimization
by setting up droplets containing equal volumes of protein and
reservoir solution at 2–3 ml and placing each droplet over 0.5 ml
reservoir solution. Crystal clusters with estimated sizes up to 1 mm
could be obtained within 7–10 days at 288 K.
Crystals were tested for diffraction quality and for cryoprotection
in-house with a Rigaku RU-H3R X-ray generator and a MAR345
imaging-plate scanner.The X-ray diffraction data sets reported in this
study were collected at 100 K using either a MAR300 CCD or a
MAR225 CCD detector on the SER-CAT beamline of the Advanced
Photon Source (APS), Argonne National Laboratory (ANL). The
raw diffraction data were processed using the program HKL-2000
(Otwinowski & Minor, 1997). Statistics indicating the quality of the
diffraction data sets are given in Table 1.
3. Results and discussion
CFA/I ﬁmbriae contain a single copy of CfaE, a tip-localized adhesive
subunit, and >1000 copies of CfaB, the stalk-forming major subunit.
Both are necessary for ﬁmbrial assembly. We have previously
reported the crystal structure of an in cis donor-strand complemented
form of CfaE (Li et al., 2006, 2007; Poole et al., 2007). However,
solution of the crystal structure of CfaB is a prerequisite for a
crystallization communications
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Table 1
Characterization of CfaEB, CfaBB and CfaBBB crystals and their diffraction
statistics.
Values in parentheses are for the outer resolution shell.
CfaEB CfaBB CfaBBB
Wavelength (A ˚ ) 0.7500 1.0000 0.7500
Beamline 22-ID, APS 22-ID, APS 22-ID, APS
Exposure time (s) 5 2 4.5
Resolution (A ˚ ) 50–2.10 (2.18–2.10) 50–2.25 (2.33–2.25) 50–2.10 (2.18–2.10)
Space group P21 P21212 C2
Unit-cell parameters
a (A ˚ ) 67.14, 75.21 127.53
b (A ˚ ) 45.16 134.82 44.81
c (A ˚ ) 128.32 65.07 98.11
  ( ) 9 09 09 0
  ( ) 97.31 90 125.41
  ( ) 9 09 09 0
No. of observations 290802 184126 124305
No. of unique reﬂections 44915 32280 25005
Mosaicity ( ) 0.642 0.227 0.375
Rmerge† 0.062 (0.229) 0.095 (0.388) 0.079 (0.401)
Completeness (%) 92.0 (75.5) 96.5 (83.4) 93.5 (71.9)
Average I/ (I) 23.0 (7.1) 15.4 (2.4) 17.3 (3.4)
Redundancy 7.0 5.6 5.0
† Rmerge is deﬁned as
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the
intensity for the ith observation of a reﬂection with Miller indices hkl and hI(hkl)i is the
mean intensity for all measured values of I(hkl) and its Friedel pair.
Figure 1
SDS–PAGE of puriﬁed CfaEB, CfaBB and CfaBBB.crystallization communications
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Figure 2
Crystals and X-ray diffraction patterns for CfaEB, CfaBB and CfaBBB. (a) Typical crystals of CfaEB. (b) X-ray diffraction pattern of a CfaEB crystal. (c) Crystals of CfaBB.
(d) Diffraction image of a CfaBB crystal. (e) A clustered crystal of CfaBBB. (f) Diffraction pattern of a CfaBBB crystal severed from the crystal shown in (e). The circles in
(b), (d) and (f) are 3 A ˚ resolution markers.complete and more detailed understanding of the general function of
CFA/I at submolecular resolution.
3.1. Strategy in making CfaB fusion proteins
In the reported crystal structure of CfaE, the donor-strand com-
plementation principle was employed to engineer an in cis donor-
strand complemented CfaE (dscCfaE) by covalently attaching a
peptide fragment (donor strand) from the N-terminus of CfaB to the
C-terminal end of CfaE, thereby ﬁlling in the hydrophobic groove of
CfaE for the missing G-strand to complete the IgG fold. We sought to
use the same approach for the structure solution of the major subunit
CfaB. An expression vector for the production of donor-strand
complemented CfaB (dscCfaB) was constructed and protein was
puriﬁed, but the puriﬁed dscCfaB never crystallized owing to its
extraordinary solubility in solution even at a protein concentration as
high as 80 mg ml
 1 (data not shown). A different approach was then
devised by extending the donor strand in the dscCfaE construct into
the main body of CfaB to create the fusion protein CfaEB; the
extended CfaB domain was again donor-strand complemented in cis.
The resulting fusion protein is better suited to crystallization and for
solving the crystallographic phase problem since the structure of
CfaE is already known (see below).
An added beneﬁt of the CfaEB fusion is that it may provide the
geometric relation between the two pilin subunits in the native pilus.
Similarly, structure determinations for the fusion proteins of two or
three major pilin subunits connected in tandem, CfaBB and CfaBBB,
are essential for constructing an atomic model of the CFA/I pilus.
3.2. Protein purification and crystallization
The pET24-2lnkdsc19cfaEB(his)6, pET24-2lnkdsc15cfaBB(his)6 and
pET24-3lnkdsc15cfaBBB(his)6 plasmids for expression of the donor-
strand complemented CfaEB heterodimeric, CfaBB homodimeric
and CfaBBB homotrimeric fusions were constructed by insertion into
a pET24a(+) plasmid with genes coding for covalent minor–major,
major–major and major–major–major pilin fusions, respectively.
Short DNA sequences coding for DNKQ-dsc19 (Poole et al., 2007)
and DNKQ-dsc15 were incorporated in two positions for CfaEB and
CfaBB and in three positions for CfaBBB, between the two genes and
after the last CfaB, to complete the donor-strand complementation. A
hexahistidine afﬁnity tag is present at the C-terminus in all constructs
After transformation into E. coli strain BL21(DE3), protein over-
expression was obtained for all constructs upon IPTG induction.
While CfaEB was puriﬁed by sequential nickel-afﬁnity column and
ion-exchange chromatography, CfaBB and CfaBBB were puriﬁed by
nickel-afﬁnity chromatography followed by hydrophobic chromato-
graphy (Fig. 1).
Each puriﬁed protein was analyzed by size-exclusion chromato-
graphy to ensure monodispersity and concentrated to approximately
10 mg ml
 1 before crystallization experiments. The CfaEB protein
was solubilized in a buffer containing 20 mM MES pH 6.0 plus
100 mM NaCl. The ﬁnal crystallization condition for CfaEB was a
mixture in a hanging-drop setup of 1 ml protein solution with 1 ml well
solution consisting of 10–11% PEG 8000, 200 mM ammonium sulfate,
100 mM citrate pH 4.0. For CfaBB crystallization, 10 mg ml
 1 protein
in a buffer containing 20 mM Tris–HCl pH 7.5 in the presence of
200 mM NaCl was mixed in a 1:1 ratio with a well solution containing
30% PEG 8000 and 200 mM ammonium sulfate. Similarly, the
CfaBBB protein (10 mg ml
 1 in 20 mM Tris–HCl pH 7.5, 100 mM
NaCl) was crystallized by mixing it in a 1:1 ratio with 22% PEG 4000,
100 mM ammonium sulfate, 100 mM sodium citrate pH 3.5, 1%
ethylene glycol, 2% PEG 400, 1% 2-propanol, 10 mM MgCl2 and
0.3% 1,2,3-heptanetriol. This condition was obtained after optimi-
zation by pH and additive screening. Crystals of CfaEB often grew in
clusters with well deﬁned morphology (Fig. 2a), whereas those of
CfaBB and CfaBBB exhibited rod-like shapes with rough surfaces
and also formed clusters (Figs. 2c and 2e).
3.3. Cryoprotection and initial X-ray diffraction analysis
We found that an additional 10% PEG 400 was sufﬁcient for
cryoprotection of all crystals during freezing and diffraction data
collection. Crystals of CfaEB were well shaped and often formed
clusters (Fig. 2a). Crystals (0.1   0.1   0.2 mm) in a cluster were
separated prior to X-ray diffraction experiments and gave a diffrac-
tion limit beyond 2 A ˚ resolution (Fig. 2b). The crystals belonged to a
monoclinic space group, with unit-cell parameters a = 67.14, b= 45.16,
c = 128.32 A ˚ ,  = 97.31 . The merged data set was 92.0% complete to
2.10 A ˚ resolution, with an Rmerge of 6.2% and a mean I/ (I)o f7 . 0
(Table 1). A screw axis must be present, as noted from systematic
absences for 0k0( k =2 n + 1) reﬂections, permitting the assignment of
space group P21. The Matthews coefﬁcient (VM) was calculated as
3.2 A ˚ 3 Da
 1, assuming the presence of one molecule of CfaEB per
crystallographic asymmetric unit, indicating a solvent content of
about 62% (Matthews, 1968).
Crystals of CfaBB were considerably more radiation-sensitive than
those of CfaEB. Fortunately, these crystals belonged to a higher
symmetry orthorhombic space group (Fig. 2d) and the time required
to complete a data-collection run was further reduced by short
exposure times. Although the diffraction limits for CfaBB crystals
were similar to those of CfaEB, the merged data set was 96.5%
complete only to 2.25 A ˚ resolution, with an Rmerge of 9.5% and an
average I/ (I) of 5.6 (Table 1). Systematic absences indicated that
these crystals possessed the symmetry of space group P21212. The
calculated VM value was 2.5 A ˚ 3 Da
 1, assuming the presence of two
CfaBB molecules in the asymmetric unit, with a solvent content of
about 51% (Matthews, 1968).
More so than CfaBB crystals, CfaBBB crystals tended to cluster
(Fig. 2e). Crystals used for diffraction data collection had to be
severed with a knife from the tips of the cluster. These crystals were
cryoprotected for data collection and diffracted X-rays to better than
2A ˚ resolution using synchrotron radiation (Fig. 2f). CfaBBB crystals
had the symmetry of space group C2 and unit-cell parameters
a = 127.53, b = 44.81, c = 98.11 A ˚ ,   = 125.41 . A data set with 93.5%
completeness was obtained at 2.10 A ˚ resolution (Table 1) with a
merging R factor of 0.079. A VM value of 3.2 A ˚ 3 Da
 1 was obtained
based on the presence of a single CfaBBB molecule in the asym-
metric unit.
3.4. Phase determination
Because the structure of a donor-strand complemented adhesive
subunit CfaE from CFA/I ﬁmbriae (PDB code 1hb0) has recently
been reported (Li et al., 2006, 2007), the crystallographic phase
problem could be solved for the CfaEB fusion crystal by the
molecular-replacement (MR) method, obviating the need to obtain
heavy-metal or selenomethionine derivatives. A clear solution with a
Z score of approximately 15 was obtained with the MR program
Phaser (Storoni et al., 2004). Initial reﬁnement with REFMAC
(Murshudov et al., 1997) in the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994) using the Phaser-generated
CfaE coordinates gave rise to an R factor and Rfree of 0.372 and 0.394,
respectively, and produced clear additional electron density corre-
sponding to the CfaB domain in the fusion, permitting model building
of the major pilin subunit. With the unreﬁned coordinates for the
crystallization communications
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CfaBB data set; four solutions were obtained, representing two
CfaBB fusion molecules per asymmetric unit. The R factor and Rfree
for the ﬁrst cycle of reﬁnement with REFMAC5 were 0.303 and 0.326,
respectively. The CfaBBB data set was similarly phased using the
coordinates of the CfaB subunit from the CfaEB structure. When all
three CfaB subunits had been identiﬁed and put into reﬁnement in
REFMAC5 in the CfaBBB structure, the R factor and Rfree for the
initial cycle were 0.235 and 0.341, respectively. Model building,
reﬁnement and structure description of the CfaEB, CfaBB and
CfaBBB fusions will be reported separately.
The authors wish to thank the staff members of the SER-CAT
beamline at APS, ANL for their assistance in data collection. This
research was supported in part by the Intramural Research Program
of the NIH, National Cancer Institute, Center for Cancer Research,
by a grant from the Trans NIH/FDA Intramural Biodefense Program
(to DX), by the US Army Military Infectious Diseases Research
Program Work Unit Number A0307 (to SJS) and by the Henry M.
Jackson Foundation for the Advancement of Military Medicine (SJS).
The views expressed in this article are those of the authors and do not
necessarily reﬂect the ofﬁcial position of the Department of the Navy,
Department of Defense or the US government.
References
Anantha, R. P., McVeigh, A. L., Lee, L. H., Agnew, M. K., Cassels, F. J., Scott,
D. A., Whittam, T. S. & Savarino, S. J. (2004). Infect. Immun. 72, 7190–7201.
Anderson, K. L., Billington, J., Pettigrew, D., Cota, E., Simpson, P., Roversi, P.,
Chen, H. A., Urvil, P., du Merle, L., Barlow, P. N., Medof, M. E., Smith,
R. A. G., Nowicki, B., Le Bouguenec, C., Lea, S. M. & Matthews, S. (2004).
Mol. Cell, 15, 647–657.
Black, R. E., Merson, M. H., Huq, I., Alim, A. R. & Yunus, M. (1981). Lancet,
1, 141–143.
Choudhury, D., Thompson, A., Stojanoff, V., Langermann, S., Pinkner, J.,
Hultgren, S. J. & Knight, S. D. (1999). Science, 285, 1061–1066.
Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50,
760–763.
Evans, D. G., Evans, D.J. Jr,Tjoa,W.S. &DuPont, H.L. (1978). Infect. Immun.
19, 727–736.
Gaastra, W. & Svennerholm, A. M. (1996). Trends Microbiol. 4, 444–452.
Hibberd, M. L., McConnell, M. M., Willshaw, G. A., Smith, H. R. & Rowe, B.
(1991). J. Gen. Microbiol. 137, 1963–1970.
Li, Y.-F., Poole, S., Rasulova, F., Esser, L., Savarino, S. J. & Xia, D. (2006). Acta
Cryst. F62, 121–124.
Li, Y.-F., Poole, S. T., Rasulova, F., McVeigh, A., Savarino, S. J. & Xia, D.
(2007). J. Biol. Chem. 282, 23970–23980.
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–494.
Mu, X. Q., Savarino, S. J. & Bullitt, E. (2008). J. Mol. Biol. 376, 614–620.
Munson, G. P., Holcomb, L. G., Alexander, H. L. & Scott, J. R. (2002). J.
Bacteriol. 184, 1196–1199.
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst. D53,
240–255.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326.
Pettigrew, D., Anderson, K. L., Billington, J., Cota, E., Simpson, P., Urvil, P.,
Rabuzin, F., Roversi, P., Nowicki, B., du Merle, L., Le Bouguenec, C.,
Matthews, S. & Lea, S. M. (2004). J. Biol. Chem. 279, 46851–46857.
Poole, S. T., McVeigh, A. L., Anantha, R. P., Lee, L. H., Akay, Y. M., Pontzer,
E. A., Scott, D. A., Bullitt, E. & Savarino, S. J. (2007). Mol. Microbiol. 63,
1372–1384.
Rowe, B., Taylor, J. & Bettelheim, K. A. (1970). Lancet, 1, 1–5.
Sakellaris, H., Balding, D. P. & Scott, J. R. (1996). Mol. Microbiol. 21, 529–541.
Sakellaris, H., Penumalli, V. R. & Scott, J. R. (1999). J. Bacteriol. 181, 1694–
1697.
Sakellaris, H. & Scott, J. R. (1998). Mol. Microbiol. 30, 681–687.
Sauer, F. G., Fu ¨tterer, K., Pinkner, J. S., Dodson, K. W., Hultgren, S. J. &
Waksman, G. (1999). Science, 285, 1058–1061.
Soto, G. E. & Hultgren, S. J. (1999). J. Bacteriol. 181, 1059–1071.
Steinsland, H., Valentiner-Branth, P., Grewal, H. M., Gaastra, W., Molbak,
K. K. & Sommerfelt, H. (2003). Diagn. Microbiol. Infect. Dis. 45, 97–105.
Storoni, L. C., McCoy, A. J. & Read, R. J. (2004). Acta Cryst. D60, 432–
438.
Turner, A. K., Beavis, J. C., Stephens, J. C., Greenwood, J., Gewert, C., Thomas,
N., Deary, A., Casula, G., Daley, A., Kelly, P., Randall, R. & Darsley, M. J.
(2006). Infect. Immun. 74, 1062–1071.
Van Molle, I., Joensuu, J. J., Buts, L., Panjikar, S., Kotiaho, M., Bouckaert, J.,
Wyns, L., Niklander-Teeri, V. & De Greve, H. (2007). J. Mol. Biol. 368,
791–799.
Verger, D., Bullitt, E., Hultgren, S. J. & Waksman, G. (2007). PLoS Pathog. 3,
e73.
Zavialov, A. V., Berglund, J., Pudney, A. F., Fooks, L. J., Ibrahim, T. M.,
MacIntyre, S. & Knight, S. D. (2003). Cell, 113, 587–596.
crystallization communications
Acta Cryst. (2009). F65, 242–247 Li et al.   CfaB subunit of CFA/I fimbriae 247